key: cord-0923462-31vt50pk
authors: Mallet, Vincent; Schwarzinger, Michaël
title: Reply Prognosis of Covid-19 patients with chronic liver disease in France in 2020
date: 2021-10-02
journal: J Hepatol
DOI: 10.1016/j.jhep.2021.09.022
sha: 8b63e67c11f2a1a825aef2882ffa74b47301d0b5
doc_id: 923462
cord_uid: 31vt50pk

nan

Financial support The study did not receive any external funding

Contributorship statement VM, MS: conception of the study, analysis and interpretation of the data, draft of the manuscript. All other members of the Demosthenes group facilitated the study or took care of the reported patients. We are not sure what the correspondents meant by "selection criteria to conduct multivariate analyzed", but no selection procedure was applied among covariates in the multivariate regression analysis given the large sample size.

In addition, issues of multicollinearity, a concern for our correspondents, were unlikely given the large sample size: the median variance inflation factor was 

Factors associated with COVID-19-related death using OpenSAFELY

High rates of 30-day mortality in patients with cirrhosis and COVID-19

Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies

Impact of chronic liver disease on outcomes of hospitalized patients with COVID-19: A multicentre United States experience

Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study

Generalized Collinearity Diagnostics